http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1455624-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f07293d4b34d8372fb0775181fef9d23
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03G15-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G03G15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-50
filingDate 1974-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1455624-A
titleOfInvention Imidazoline derivatives
abstract 1455624 2 - Phenylaminoimidazolines - (2) BOEHRINGER INGELHEIM GmbH 22 Feb 1974 [23 Feb 1973] 8202/74 Heading C2C Novel 2 - phenylaminoimidazolines - (2) of the general formula wherein each of R 1 , R 2 and R 3 is a hydrogen, fluorine, chlorine or bromine atom or a methyl, ethyl, methoxy, trifluoromethyl or cyano group and each of R 4 and R 5 , which must be different, is a hydrogen atom or a group of formula in which R 6 is a hydrogen atom or a methyl or ethyl group, with the proviso that one of R 4 and R 5 is a hydrogen atom, and acid addition salts thereof are prepared (a) when R 5 is a hydrogen atom, by reacting the corresponding compound in which R 4 is a hydrogen atom with a compound of the general formula wherein Hal is a chlorine, bromine or iodine atom; (b) when R 5 is a hydrogen atom, by reacting a compound of the general formula wherein A is a cyano or -C(=NH)Y group, in which Y is an atom or group removable as an anion, with ethylene diamine or an acid addition salt thereof; (c) when R 4 is a hydrogen atom, by reacting a compound of the general formula wherein X is as Y above, with a compound of the general formula and (d) by reacting a compound of the general formula wherein M is a metal and n represents the charge on the cation, with a compound of the second general formula above; and, if desired, converting a resulting free base into an acid addition salt thereof. Pharmaceutical compositions having analgesic and blood pressure-reducing activity comprise, as active ingredient, at least one 2-phenylaminoimidazoline-(2) or physiologically compatible acid addition salt thereof, in association with a pharmaceutical carrier or excipient.
priorityDate 1973-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415835321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137235

Total number of triples: 36.